Clinicopathologic and molecular features in cutaneous extranodal natural killer–/T-cell lymphoma, nasal type, with aggressive and indolent course - 14/03/14
Abstract |
Background |
Extranodal natural killer–/T-cell lymphoma, nasal type (ENKTCL-NT) is a highly aggressive lymphoma and prognosis is usually poor. The genetic background of primary cutaneous cases is poorly understood.
Objective |
We sought to evaluate the clinicopathologic features of cutaneous ENKTCL-NT, and the prognostic significance of genomic copy number alterations.
Methods |
Eight cases of cutaneous ENKTCL-NT (5 primary, 2 secondary, 1 no staging performed), including 2 patients with an unusually prolonged course of 5 and 23 years, were investigated using array comparative genomic hybridization.
Results |
All patients presented with typical clinicopathologic features. Epstein-Barr virus was found in neoplastic cells in all specimens. Copy number alterations were detected in all 8 cases with losses on 6q (37.5% of cases) and 7p (37.5% of cases), and gains on 7q (37.5% of cases) being the most frequent. Complexity of array comparative genomic hybridization profile did not correlate with the course of the disease. However, an increase of copy number alterations was detected in sequential biopsy specimens of 1 long-term survivor.
Limitations |
This was a small case series retrospective study.
Conclusion |
Clinicopathologic features of cutaneous ENKTCL-NT are distinctive. Lower number of copy number alterations cannot be used as predictor for prolonged survival in cutaneous ENKTCL-NT.
Le texte complet de cet article est disponible en PDF.Key words : array comparative genomic hybridization, clinicopathologic features, cutaneous T-cell lymphoma, extranodal natural killer–/T-cell lymphoma, nasal type, genomic aberrations, prognosis
Abbreviations used : aCGH, ARF, CDKN2A, EBER, ENKTCL-NT, NF2, NK, p53, PCR, TIA-1, WHO
Plan
| Supported in part by the Jubiläumsfonds of the Oesterreichische Nationalbank (OeNB 13837). |
|
| Conflicts of interest: None declared. |
Vol 70 - N° 4
P. 716-723 - avril 2014 Retour au numéro
Article précédent
- Treatment of indolent primary cutaneous B-cell lymphomas with subcutaneous interferon-alfa
- Staffan Vandersee, Dorothea Terhorst, Daniel Humme, Marc Beyer
- Cutaneous nonmycotic T- and natural killer/T-cell lymphomas: Diagnostic challenges and dilemmas
- Shih-Sung Chuang, Young-Hyeh Ko
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?